Precigen, Inc. - Common Stock (PGEN)
1.5500
+0.0300 (1.97%)
NASDAQ · Last Trade: Jul 23rd, 9:52 AM EDT
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · July 22, 2025
Via Benzinga · July 22, 2025
Via Benzinga · July 9, 2025
Via Benzinga · July 2, 2025
Via Benzinga · March 21, 2025

Via Benzinga · January 23, 2025

Stocks are struggling for direction in the first trading session of the year.
Via Talk Markets · January 2, 2025

Precigen submits BLA for PRGN-2012 gene therapy targeting RRP, a rare and life-threatening condition with no cure.
Via Benzinga · December 30, 2024

Via Benzinga · August 15, 2024

Via Benzinga · August 15, 2024

PGEN stock results show that Precigen missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 14, 2024

Via Benzinga · August 14, 2024

Via Benzinga · August 8, 2024

Via Benzinga · June 3, 2024

PGEN stock results show that Precigen missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 14, 2024

PGEN stock results show that Precigen missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 19, 2024

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.
Via Benzinga · March 21, 2024

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.
Via Benzinga · March 19, 2024